MedPath

a clinical trial on the effects of the umbilical cord being cut after squeezing cord blood towards the baby, on the mother and newborns beyond 34 weeks

Not Applicable
Completed
Conditions
Health Condition 1: null- Pregnant women with period of gestation from 34 0/7 to 40 6/7 weeks
Registration Number
CTRI/2017/10/009970
Lead Sponsor
Anu Anna George
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
170
Inclusion Criteria

Expectant mothers with a period of gestation between 34 0/7 and 40 6/7 weeks admitted in our hospital, for safe confinement or in labour.

Exclusion Criteria

Rh-negative mothers and those with h/o bleeding disorders.

HIV and Hbs Ag positive mothers

Pregnancies complicated by cord prolapse, placenta previa, placental abruption, or cord abnormalities

Neonates who are 1 of a set of multiples, born with a short umbilical cord ( < 25 cm), a major congenital anomaly, hydropsfetalis, or limpness at birth.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Infant hemoglobin and hematocrit measured using a portable hemoglobinometerTimepoint: 3 days and 6 weeks
Secondary Outcome Measures
NameTimeMethod
Infant bilirubin (trans cutaneous bilirubin )Timepoint: 3 days of age;Need for photo therapyTimepoint: 3 days of age till discharge;Post partum complicationsTimepoint: At delivery
© Copyright 2025. All Rights Reserved by MedPath